The largest database of trusted experimental protocols

Cytotox 96 cytotoxicity assay

Manufactured by Promega
Sourced in United States

The CytoTox 96 cytotoxicity assay is a colorimetric method for quantifying the release of lactate dehydrogenase (LDH) from damaged cells. It provides a simple and reliable way to measure cytotoxicity in a variety of cell types.

Automatically generated - may contain errors

23 protocols using cytotox 96 cytotoxicity assay

1

Evaluating Fatty Acid Cytotoxicity on HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To asses FA cytotoxicity, HUVEC were cultured in 96-well plates to 90–100% confluence, then exposed to EtOH, BSA, or MBCD solubilized OA, 12-OH OA, 2-OH OA (Na+), me-OA or vehicle controls, in quadruplicate, for 4, 24, or 48 h. Cell supernatants were collected immediately following exposure for use with the Promega Cytotox-96 cytotoxicity assay (Promega Corporation, Madison, WI) to measure supernatant lactate dehydrogenase (LDH) activity release. In some experiments, cell viability was visualized with standard light microscopy techniques by exclusion of trypan blue dye.
+ Open protocol
+ Expand
2

Pulmonary Inflammation and Damage Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell damage and inflammatory markers were assessed within LLF of the mice. Cell damage was determined by release of lactate dehydrogenase (LDH; CytoTox 96 cytotoxicity assay, Promega; Madison, WI, USA) and protein concentration (Pierce BCA protein assay, Thermo Fisher Scientific; Waltham, MA, USA) according to manufacturer’s instructions. Cytokines were quantitated by using a customized MesoScale Discovery U-PLEX assay platform (IFNγ, IL-1β, TNFα, IL-33, IL-6, IL-10, IL-13; Meso Scale Diagnostics LLC; Rockville, MD, USA) according to manufacturer’s instructions. Phagolysosomal membrane permeability (LMP) analysis was determined by total cathepsin (CTS; Z-LR-AMC fluorogenic peptide substrate, R&D Systems; Minneapolis, MN, USA) and cathepsin B (cathepsin B inhibitor II—Calbiochem, Millipore Sigma; Burlington, MA, USA) release within the LLF and IL-1β release (mouse IL-1β DuoSet ELISA, R&D Systems) within the supernatants of isolated ex vivo AM.
+ Open protocol
+ Expand
3

LDH Release Assay for Pyroptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lactate dehydrogenase (LDH) release has been perceived as a hallmark of pyroptosis. CytoTox 96 Cytotoxicity Assay (Promega, Madison, WI, USA) was used to detect LDH activity in the supernatants after the indicated treatments. The activity of released LDH is expressed as a proportion of the total LDH in the cell lysate.
+ Open protocol
+ Expand
4

FLS Proliferation Assay with RTD-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
FLS were seeded at 3 × 103 cells/well in a 96-well TC treated plate (Greiner). Cells were allowed to adhere for 18 h and medium was replaced prior to addition of peptide or vehicle. RTD-1 was added to wells at final concentrations of 0–30 μg/ml in culture medium and incubated for 0, 24, or 48 h at 37°C in 5% CO2. FLS cell number was determined by DNA staining using CyQuant Cell Proliferation Assay Kit (Invitrogen) per manufacturer’s instructions. Cellular toxicity was determined by measuring the release of lactate dehydrogenase (LDH) using a CytoTox 96 Cytotoxicity Assay (Promega Bio Sciences, San Luis Obispo, CA) in FLS supernatants. All assays were performed with ≥ 7 replicates.
+ Open protocol
+ Expand
5

Cell viability and cytotoxicity assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in a 96-multiwell at a density of 10 000 cells per well. After 24 h, correctors dissolved in 1‰ DMSO were added at the indicated concentrations. After 24 h of treatment, cell viability was determined measuring the bioreduction of MTS (Owen’s reagent) by living cells with the Cell Titer 96 Aqueous proliferation assay (Promega) according to the manufacturer’s instruction. Cell toxicity was determined measuring the release of LDH in culture supernatant with the Cytotox 96 cytotoxicity assay (Promega) according to the manufacturer’s instruction. A maximum LDH release control was performed adding a lysis solution 45 min before adding Cytotox 96 reagent, and LDH release was calculated as (experimental LDH release-blank)/(maximum LDH release-blank)×100.
All spectrophotometric measurements were performed with a Novapath Microplate Reader (Bio-Rad). All experiments were run in sextuplicate.
+ Open protocol
+ Expand
6

Cytotoxicity Quantification via LDH Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Culture supernatants were collected and centrifuged at 250×g for 5 min after treatments. The LDH concentration was measured with the CytoTox 96 cytotoxicity assay (G1780, Promega, USA) at 490 nm according to the protocol offered by the manufacturer. The percentage of LDH release was calculated as follows: (Sample  −  Background)/(Maximum − Background)  ×  100%. Each subject was repeated at least three times.
+ Open protocol
+ Expand
7

Cell Viability Assay with TGFβ-1 and E64d

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine cell viability 1.5×104 cells were seeded in 9.6 cm2 wells. After two days cells were washed three times with DPBS and switched to indicator free growth medium containing 5% FCS supplemented with or without TGFβ-1+/−E64d in triplicates. Cell viability was assayed by LDH activity using the Cytotox 96® cytotoxicity assay (Promega) according to the manufacturer’s instructions. To compile growth curves, every two days cells of three wells of one condition were pooled, diluted in Trypan blue stain and living cells were counted using a Neubauer counting chamber.
+ Open protocol
+ Expand
8

Quantifying Lung Damage and Vascular Leakage

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess lung damage, bronchoalveolar lavage fluid was analyzed by measuring lactate dehydrogenase levels using a CytoTox 96 Cytotoxicity Assay (Promega) following the manufacturer’s instructions. To assess vascular/pulmonary leakage, bronchoalveolar lavage fluid was analyzed using an Albumin BCG Reagent Set (Eagle Diagnostics). A standard curve was made by diluting the calibrator in PBS. Then 100 μl of sample or standard was transferred to a 96 well flat-bottomed plate, mixed with 100 μl of BCG reagent, let sit at RT for 5 min and then read on a plate reader at 630 nm.
+ Open protocol
+ Expand
9

Quantifying Lung Damage and Vascular Leakage

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess lung damage, BALF from 72 h post-inoculation was analyzed by measuring lactate dehydrogenase levels using a CytoTox 96® Cytotoxicity Assay (Promega) following the manufacturer’s instructions. To assess vascular/pulmonary leakage, BALF was analyzed using an Albumin BCG Reagent Set (Eagle Diagnostics, Cedar Hill, TX, United States). A standard curve was made by diluting the calibrator in PBS/EDTA. Then 100 μl of sample or standard was transferred to a 96 well flat-bottomed plate, mixed with 100 μl of BCG reagent, let sit at RT (room temperature) for 5 min and then read on a plate reader at 630 nm.
+ Open protocol
+ Expand
10

Quantifying Parasite Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Parasites suspended in Ringer's solution at 5 × 105 parasites/ml were pretreated with varying concentrations of zaprinast (as indicated) for 20 min at 37 °C with 5% CO2. 105 parasites/well were then applied to confluent host cell monolayers, and plates were centrifuged at 290 × g for 5 min. Following 1 h at 37 °C with 5% CO2, plates were centrifuged again at 500 × g for 5 min. 50 μl of supernatant were collected from each well, and lactate dehydrogenase was quantified using the CytoTox 96 cytotoxicity assay (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!